Heron Therapeutics stock continues soaring
June 01, 2015 at 18:53 PM EDT
Heron Therapeutics Inc. (Nasdaq: HRTX) announced positive results from a Phase 3 MAGIC study of SUSTOL sending the stock price leaping $4.61 to close at $24.37.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.